Gene: TMEM241
Official Full Name: transmembrane protein 241provided by HGNC
Gene Summary: Enables UDP-N-acetylglucosamine transmembrane transporter activity. Involved in UDP-N-acetylglucosamine transmembrane transport. Located in Golgi apparatus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO24322 | TMEM241 Knockout cell line (HeLa) | Human | TMEM241 | 1:3~1:6 | Negative | Online Inquiry |
KO24323 | TMEM241 Knockout cell line (HCT 116) | Human | TMEM241 | 1:2~1:4 | Negative | Online Inquiry |
KO24324 | TMEM241 Knockout cell line (HEK293) | Human | TMEM241 | 1:3~1:6 | Negative | Online Inquiry |
KO24325 | TMEM241 Knockout cell line (A549) | Human | TMEM241 | 1:3~1:4 | Negative | Online Inquiry |
TMEM241 Gene Knockout Cell Lines represent a cutting-edge tool designed to facilitate molecular and cellular research through the targeted ablation of the TMEM241 gene. These cell lines are engineered using CRISPR-Cas9 technology, which allows for precise editing of the genome, leading to the complete knockout of theTMEM241 gene. This approach enables researchers to study the gene's functional role in various biological processes, including cell proliferation, survival, and intracellular signaling pathways.
The primary function of these cell lines lies in their ability to allow scientists to investigate the impact of TMEM241 deficiency on cellular behavior, both in vitro and in vivo. By observing the phenotypic changes that occur as a result of gene knockout, researchers can gain valuable insights into the physiological relevance of TMEM241. This knowledge is crucial for elucidating the gene's involvement in diseases, potentially uncovering new therapeutic targets for conditions where TMEM241 is implicated.
The scientific importance of TMEM241 Gene Knockout Cell Lines extends to both basic and applied research settings. In basic research, they serve as an invaluable resource for gene function studies. In clinical settings, they enhance drug discovery and validation processes, providing a robust platform for preclinical testing of therapeutics aimed at modulating TMEM241-related pathways.
Unlike traditional knockout models, these cell lines offer the unique advantage of rapid generation and upstream characterization, which significantly accelerates research timelines. Additionally, they reduce ethical concerns associated with animal models, allowing for a more humane and efficient research approach.
For researchers and clinicians aiming to explore the complexities of gene function, the TMEM241 Gene Knockout Cell Lines provide a well-characterized, highly reproducible system that can drive innovative discoveries. Our company specializes in the development of state-of-the-art genetic tools, ensuring the highest quality products for your research needs. With our expertise in gene editing technologies, we are committed to supporting scientific advancements in a range of fields.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.